マーケットレポート詳細

血液検査製品・サービスの世界市場:技術別、製品別、主要国地域別2026年予測

Blood Screening Market by Technology (Nucleic Acid Amplification, (Real-Time PCR), ELISA (Chemiluminescence immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecast to 2026

出版元:MarketsandMarkets   出版元について
発行年:2021年12月
定価 :Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文237ページになります。
商品コード:MAM2769

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

血液検査製品・サービスの世界市場規模は2021年で25億ドル、2026年には38億ドルに拡大すると予測されています。期間中の同市場の平均年成長率は8.4%で推移する見込みです。
血液検査製品・サービス市場の成長要因は、主に輸血/献血数の増加に起因するでしょう。さらに、血液スクリーニング技術の技術的進歩と手術の増加は、成長を促進しています。

レポートは血液検査製品・サービスの世界市場について2026年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測(製品/サービス別市場、技術別市場、等)を中心に構成されています。また競合状況、主要企業情報(10社)、COVID-19による血液検査製品・サービス市場への影響、価格分析などの分析も加味し、血液検査製品・サービス市場の動向および今後成長性を詳細にレポートしています。

【レポート構成概要】

◆血液検査製品・サービスの世界市場予測2019-2026年

・市場規模(US$)

◆製品/サービス別、市場-2026年

試薬/キット
・NAT試薬/キット
-酵素/ポリメラーゼ
-標準/コントロール
-プローブ/プライマー
-バッファー/ヌクレオチド/溶液
-ラベリング/検出試薬

・ELISA試薬/キット
-免疫吸着剤
-コントロール
-コンジュゲート
-基質
-サンプル希釈材/洗浄液

・その他試薬/キット

装置
・レンタル購入
・完全購入

ソフトウェア/サービス
※(市場規模US$) 

◆技術別、市場-2026年

核酸検査(NAT)
・転写媒介増幅(TMA)
・リアルタイムポリメラーゼ連鎖反応

酵素免疫測定法(ELISA)
・化学発光イムノアッセイ(CLIA)
・蛍光イムノアッセイ(FIA)
・比色イムノアッセイ(CIA)

ラピッドテスト
ウエスタンブロットアッセイ
次世代シーケンシング
※(市場規模US$) 

◆エンドユーザー別、市場-2026年

・血液銀行
・病院
※(市場規模US$) 

◆主要国地域別市場-2026年

北米
・米国、カナダ
欧州
・ドイツ、フランス、英国、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、オーストラリア
・その他アジア太平洋
中南米
・ブラジル
・その他中南米
中東アフリカ
※国地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

◆市場分析

・市場ダイナミクス(ドライバー、障壁、機会、課題)
・COVID-19による血液検査製品・サービス市場への影響
・価格分析
・特許分析
・バリューチェーン分析
・サプライチェーン分析
・ファイブフォース分析
・事例研究
・市場シェア分析
・競合状況

◆血液検査製品・サービスの主要企業プロフィール動向

・F. HOFFMANN-LA ROCHE     
・GRIFOLS       
・ABBOTT LABORATORIES      
・BIOMÉRIEUX
・BIO-RAD LABORATORIES      
・BECTON, DICKINSON AND COMPANY            
・DANAHER CORPORATION    
・DIASORIN     
・SIEMENS HEALTHINEERS      
・THERMO FISHER SCIENTIFIC, INC.

(その他企業)
・ORTHO CLINICAL DIAGNOSTICS, INC.           
・GE HEALTHCARE      
・MERCK KGAA
・PERKINELMER           
・BIO-TECHNE CORPORATION
・GFE  
・TRINITY BIOTECH    
・J. MITRA & CO. PVT. LTD.      
・MINDRAY      
・MACCURA BIOTECHNOLOGY CO., LTD.         
・IMMUCOR, INC.         
・CELLABS       
・ABNOVA CORPORATION       
・ENZO BIOCHEM, INC.
・CEPHEID

(全237頁)


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次)

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.2.1              INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2              MARKETS COVERED
・       FIGURE 1................. BLOOD SCREENING MARKET SEGMENTATION
1.2.3              YEARS CONSIDERED FOR THE STUDY
1.3             CURRENCY
1.4             LIMITATIONS
1.5             STAKEHOLDERS
1.6             SUMMARY OF CHANGES

2.... RESEARCH METHODOLOGY

2.1             RESEARCH DATA
2.2             RESEARCH APPROACH
・       FIGURE 2............ BLOOD SCREENING MARKET: RESEARCH DESIGN
2.2.1              SECONDARY DATA
2.2.1.1            KEY DATA FROM SECONDARY SOURCES
2.2.2              PRIMARY DATA
2.2.2.1            PRIMARY SOURCES
2.2.2.2            KEY DATA FROM PRIMARY SOURCES
2.2.2.3            KEY INDUSTRY INSIGHTS
2.2.2.4            BREAKDOWN OF PRIMARY INTERVIEWS
・       FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (BLOOD SCREENING MARKET)
・       FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3             MARKET SIZE ESTIMATION
2.3.1              BOTTOM-UP APPROACH
2.3.1.1            APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
・       FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2            APPROACH 2: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
2.3.1.3            GROWTH FORECAST
2.3.1.4            CAGR PROJECTIONS
・       FIGURE 6................. CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2              TOP-DOWN APPROACH
・       FIGURE 7....... BLOOD SCREENING MARKET: TOP-DOWN APPROACH
2.4             MARKET BREAKDOWN & DATA TRIANGULATION
・       FIGURE 8.......................... DATA TRIANGULATION METHODOLOGY
2.5             MARKET SHARE
2.6             ASSUMPTIONS FOR THE STUDY
2.7             LIMITATIONS
2.8             RISK ASSESSMENT
2.8.1              RISK ASSESSMENT: BLOOD SCREENING MARKET
2.9             GROWTH RATE ASSUMPTIONS
2.10          COVID-19 HEALTH ASSESSMENT
2.11          COVID-19 ECONOMIC ASSESSMENT
2.12          ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
・       FIGURE 9................. CRITERIA IMPACTING THE GLOBAL ECONOMY
・       FIGURE 10........... RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.13          ASSESSMENT OF THE IMPACT OF COVID-19 ON THE BLOOD SCREENING MARKET

3.... EXECUTIVE SUMMARY

・       FIGURE 11... BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION)
・       FIGURE 12............. BLOOD SCREENING MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION)
・       FIGURE 13..... BLOOD SCREENING MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
・       FIGURE 14 BLOOD SCREENING MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4.... PREMIUM INSIGHTS

4.1             BLOOD SCREENING MARKET OVERVIEW
・       FIGURE 15............ GROWING NUMBER OF BLOOD DONATIONS AND INCREASING PREVALENCE OF INFECTIOUS DISEASES DRIVE MARKET GROWTH
4.2             BLOOD SCREENING MARKET SHARE, BY PRODUCT & SERVICE, 2021 VS. 2026
・       FIGURE 16............ REAGENTS & KITS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.3             BLOOD SCREENING MARKET SHARE, BY TECHNOLOGY, 2021 VS. 2026
・       FIGURE 17 NUCLEIC ACID TEST SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.4             BLOOD SCREENING MARKET SHARE, BY END USER, 2021 VS. 2026
・       FIGURE 18 BLOOD BANKS SEGMENT TO CONTINUE TO DOMINATE THE MARKET IN 2026
4.5             BLOOD SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・       FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE BLOOD SCREENING MARKET DURING THE FORECAST PERIOD

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・       FIGURE 20..... BLOOD SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

5.2.1              DRIVERS
5.2.1.1            RISING NUMBER OF BLOOD DONATIONS
・       TABLE 1................. GLOBAL CANCER PREVALENCE, 2018 VS. 2025
5.2.1.2            RISING PREVALENCE OF INFECTIOUS DISEASES AND EMERGENCE OF NEWER PATHOGENS
5.2.2              RESTRAINTS
5.2.2.1            ALTERNATIVE TECHNOLOGIES
5.2.3              OPPORTUNITIES
5.2.3.1            TECHNOLOGICAL ADVANCEMENTS
5.2.3.2            EMERGING ECONOMIES OFFER LUCRATIVE OPPORTUNITIES
5.2.4              CHALLENGES
5.2.4.1            HIGH COST OF BLOOD SCREENING TECHNOLOGIES
5.2.4.2            USAGE OF LOW-SENSITIVITY SCREENING
5.3             IMPACT OF COVID-19 ON THE BLOOD SCREENING MARKET
5.4             PESSIMISTIC, OPTIMISTIC, AND REALISTIC SCENARIOS
5.4.1              BLOOD SCREENING MARKET
・       FIGURE 21.......................................... PESSIMISTIC SCENARIO
・       FIGURE 22............................................ OPTIMISTIC SCENARIO
・       FIGURE 23.............................................. REALISTIC SCENARIO
5.5             PRICING ANALYSIS
・       TABLE 2............... PRICE OF BLOOD SCREENING PRODUCTS (2021)
5.6             PATENT ANALYSIS
5.6.1              PATENT ANALYSIS OF NAT
5.6.2              PATENT ANALYSIS OF ELISA
5.7             TRADE ANALYSIS
5.7.1              TRADE ANALYSIS FOR DIAGNOSTIC REAGENTS
・       TABLE 3 IMPORT DATA FOR DIAGNOSTIC OR LABORATORY REAGENTS ON A BACKING, PREPARED DIAGNOSTIC OR LABORATORY REAGENTS, BY COUNTRY, 2016–2020 (USD MILLION)
・       TABLE 4 EXPORT DATA FOR DIAGNOSTIC OR LABORATORY REAGENTS ON A BACKING, PREPARED DIAGNOSTIC OR LABORATORY REAGENTS, BY COUNTRY, 2016–2020 (USD MILLION)
5.8             VALUE CHAIN ANALYSIS
・       FIGURE 24 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
5.9             SUPPLY CHAIN ANALYSIS
・       FIGURE 25... BLOOD SCREENING MARKET: SUPPLY CHAIN ANALYSIS
5.10          ECOSYSTEM ANALYSIS OF THE BLOOD SCREENING MARKET
・       FIGURE 26...... BLOOD SCREENING MARKET: ECOSYSTEM ANALYSIS
5.10.1            ROLE IN ECOSYSTEM... 62
5.11          PORTER’S FIVE FORCES ANALYSIS
・       TABLE 5......... BLOOD SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.11.1            THREAT OF NEW ENTRANTS
5.11.2            THREAT OF SUBSTITUTES
5.11.3            BARGAINING POWER OF BUYERS
5.11.4            BARGAINING POWER OF SUPPLIERS
5.11.5            DEGREE OF COMPETITION
5.12          REGULATORY LANDSCAPE
5.12.1            NORTH AMERICA
5.12.1.1          US
5.12.1.2          CANADA
5.12.2            EUROPE
5.12.3            ASIA PACIFIC
5.12.3.1          JAPAN
5.12.3.2          INDIA
5.12.4            LATIN AMERICA
5.12.4.1          BRAZIL
5.12.5            MIDDLE EAST
5.13          CASE STUDY ANALYSIS
5.13.1            CASE STUDY 1
5.13.2            CASE STUDY 2
5.14          TECHNOLOGY ANALYSIS
5.15          TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS
5.15.1            REVENUE SOURCES ARE SHIFTING TOWARD TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC
・       FIGURE 27.... REVENUE SHIFT FOR THE BLOOD SCREENING MARKET

6.... BLOOD SCREENING MARKET, BY PRODUCT & SERVICE

6.1             INTRODUCTION
・       TABLE 6....... BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
6.2             REAGENTS & KITS
・       TABLE 7............. KEY PRODUCTS IN THE REAGENTS & KITS MARKET
・       TABLE 8. BLOOD SCREENING REAGENTS & KITS MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 9..... BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1              NAT REAGENTS & KITS
6.2.1.1            HIGH SENSITIVITY AND RISING USE OF NAT ARE BOOSTING THE DEMAND FOR REAGENTS & KITS
6.2.1.2            ENZYMES & POLYMERASES
6.2.1.3            STANDARDS & CONTROLS
6.2.1.4            PROBES & PRIMERS
6.2.1.5            BUFFERS, NUCLEOTIDES, AND SOLUTIONS
6.2.1.6            LABELING & DETECTION REAGENTS

6.3             PRIMARY NOTES
6.3.1              KEY INDUSTRY INSIGHTS
・       TABLE 10...... KEY PRODUCTS IN THE NAT REAGENTS & KITS MARKET
・       TABLE 11.. NAT REAGENTS & KITS MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 12 NAT REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.3.2              ELISA REAGENTS & KITS
6.3.2.1            EASE OF USE AND COST-EFFECTIVENESS OF ELISA REAGENTS & KITS WILL DRIVE THE MARKET GROWTH
6.3.2.2            IMMUNOSORBENTS
6.3.2.3            CONTROLS
6.3.2.4            CONJUGATES
6.3.2.5            SUBSTRATES
6.3.2.6            SAMPLE DILUENTS & WASH SOLUTIONS
・       TABLE 13.... KEY PRODUCTS IN THE ELISA REAGENTS & KITS MARKET
・       TABLE 14 ELISA REAGENTS & KITS MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 15.... ELISA REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.3.3              OTHER REAGENTS & KITS
・       TABLE 16.. KEY PRODUCTS IN THE OTHER REAGENTS & KITS MARKET
・       TABLE 17. OTHER BLOOD SCREENING REAGENTS & KITS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.4             INSTRUMENTS
・       TABLE 18. KEY PRODUCTS IN THE BLOOD SCREENING INSTRUMENTS MARKET
・       TABLE 19... BLOOD SCREENING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 20 BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
6.4.1              RENTAL PURCHASE. 80
6.4.1.1            CONVENIENCE AND COST-EFFECTIVENESS OF RENTING INSTRUMENTS HAS RESULTED IN A GREATER END-USER PREFERENCE
・       TABLE 21....... RENTAL PURCHASE MARKET FOR BLOOD SCREENING INSTRUMENTS, BY REGION, 2019–2026 (USD MILLION)
6.4.2              OUTRIGHT PURCHASE
6.4.2.1            AVAILABILITY OF GOVERNMENT SUPPORT WILL INCREASE THE OUTRIGHT PURCHASE OF INSTRUMENTS
・       TABLE 22.... OUTRIGHT PURCHASE MARKET FOR BLOOD SCREENING INSTRUMENTS, BY REGION, 2019–2026 (USD MILLION)
6.5             SOFTWARE & SERVICES
6.5.1              GROWING PURCHASE OF INSTRUMENTS WILL DRIVE DEMAND FOR SOFTWARE & SERVICES
・       TABLE 23.... KEY PRODUCTS IN THE SOFTWARE & SERVICES MARKET
・       TABLE 24... BLOOD SCREENING SOFTWARE & SERVICES, BY REGION, 2019–2026 (USD MILLION)

7.... BLOOD SCREENING MARKET, BY TECHNOLOGY

7.1             INTRODUCTION
・       TABLE 25...... BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
7.2             NUCLEIC ACID TEST
・       TABLE 26.............................. KEY PRODUCTS IN THE NAT MARKET
・       TABLE 27. BLOOD SCREENING MARKET FOR NAT, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 28...... BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
7.2.1              TRANSCRIPTION-MEDIATED AMPLIFICATION
7.2.1.1            HIGH SENSITIVITY OF THESE ASSAYS TO SUPPORT THE MARKET GROWTH.. 87
・       TABLE 29...... TMA MARKET, BY REGION, 2019–2026 (USD MILLION)
7.2.2              REAL-TIME POLYMERASE CHAIN REACTION
7.2.2.1            REAL-TIME PCR PROVIDES MORE ACCURATE AND EFFECTIVE RESULTS AS COMPARED TO CONVENTIONAL PCR
・       TABLE 30.. RT-PCR MARKET, BY REGION, 2019–2026 (USD MILLION)
7.3             ENZYME-LINKED IMMUNOSORBENT ASSAY
・       TABLE 31........................... KEY PRODUCTS IN THE ELISA MARKET
・       TABLE 32......... BLOOD SCREENING MARKET FOR ELISA, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 33.... BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
7.3.1              CHEMILUMINESCENT IMMUNOASSAYS
7.3.1.1            CLIA IS ULTRA-SENSITIVE, AUTOMATED, AND A GOOD ALTERNATIVE TO CONVENTIONAL TECHNOLOGIES
・       TABLE 34...... CLIA MARKET, BY REGION, 2019–2026 (USD MILLION)
7.3.2              FLUORESCENT IMMUNOASSAYS
7.3.2.1            RISING DEMAND FOR SAFER AND S・       TABLE REAGENTS AND THE DEVELOPMENT OF NOVEL MARKERS TO SUPPORT THE GROWTH OF THE FIA MARKET
・       TABLE 35....... FIA MARKET, BY REGION, 2019–2026 (USD MILLION)
7.3.3              COLORIMETRIC IMMUNOASSAYS
7.3.3.1            CI OFFERS LOW SENSITIVITY AS IT USES VULNERABLE/LIMITED SIGNAL AMPLIFICATION STRATEGIES
・       TABLE 36....... CIA MARKET, BY REGION, 2019–2026 (USD MILLION)
7.4             RAPID TESTS
7.4.1              RISING AWARENESS ABOUT RAPID TESTS IN EMERGING COUNTRIES TO DRIVE MARKET GROWTH
・       TABLE 37 KEY PRODUCTS IN THE RAPID TESTS TECHNOLOGY MARKET
・       TABLE 38 BLOOD SCREENING MARKET FOR RAPID TESTS, BY REGION, 2019–2026 (USD MILLION)
7.5             WESTERN BLOT ASSAYS
7.5.1              GROWING PREVALENCE OF TTIS IN DEVELOPING COUNTRIES HAS RESULTED IN THE INCREASED DEMAND FOR WESTERN BLOT ASSAYS
・       TABLE 39.... KEY PRODUCTS IN THE WESTERN BLOT ASSAYS MARKET
・       TABLE 40. BLOOD SCREENING MARKET FOR WESTERN BLOT ASSAYS, BY REGION, 2019–2026 (USD MILLION)

7.6             NEXT-GENERATION SEQUENCING
7.6.1              NGS IS AN EMERGING TECHNOLOGY IN THE BLOOD SCREENING MARKET
・       TABLE 41. BLOOD SCREENING MARKET FOR NGS, BY REGION, 2019–2026 (USD MILLION)

8.... BLOOD SCREENING MARKET, BY END USER

8.1             INTRODUCTION
・       TABLE 42... BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2             BLOOD BANKS
8.2.1              RISING DEMAND FOR BLOOD ATTRIBUTED TO INCREASING BLOOD DISORDER INCIDENCE
8.2.2              KEY INDUSTRY INSIGHTS
・       TABLE 43......... BLOOD SCREENING MARKET FOR BLOOD BANKS, BY REGION,
2019–2026 (USD MILLION)
8.3             HOSPITALS
8.3.1              INCREASING SURGICAL PROCEDURES WILL DRIVE THE GROWTH OF THE HOSPITALS SEGMENT
・       TABLE 44. BLOOD SCREENING MARKET FOR HOSPITALS, BY REGION, 2019–2026 (USD MILLION)

9.... BLOOD SCREENING MARKET, BY REGION

9.1             INTRODUCTION
・       TABLE 45...... BLOOD SCREENING MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2             NORTH AMERICA
・       FIGURE 28 NORTH AMERICA: BLOOD SCREENING MARKET SNAPSHOT
・       TABLE 46........... NORTH AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 47........... NORTH AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 48 NORTH AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 49. NORTH AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 50........... NORTH AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 51... NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 52....... NORTH AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 53..... NORTH AMERICA: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.1              US
9.2.1.1            THE US DOMINATED THE NORTH AMERICAN BLOOD SCREENING MARKET IN 2020
・       TABLE 54..... INCIDENCE OF VARIOUS CANCERS IN THE US, 2018 VS. 2025
・       TABLE 55. US: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 56 US: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 57 US: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 58 US: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 59..... US: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 60......... US: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 61..... US: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2              CANADA
9.2.2.1            GROWING VOLUME OF SURGICAL PROCEDURES PERFORMED AND HIGH BURDEN OF CANCER TO SUPPORT MARKET GROWTH
・       TABLE 62... CANADA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 63... CANADA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 64........ CANADA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 65..... CANADA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 66.. CANADA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 67.. CANADA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 68....... CANADA: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3             EUROPE
・       TABLE 69........ EUROPE: BLOOD SCREENING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 70... EUROPE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 71... EUROPE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 72........ EUROPE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 73...... EUROPE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 74.. EUROPE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 75.. EUROPE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 76....... EUROPE: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)

9.3.1              GERMANY
9.3.1.1            HIGHER HEALTHCARE SPENDING AND INCREASE IN CANCER PREVALENCE DRIVES MARKET GROWTH
・       TABLE 77............................. GERMANY: KEY MACROINDICATORS
・       TABLE 78. GERMANY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 79. GERMANY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 80...... GERMANY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 81... GERMANY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 82 GERMANY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 83 GERMANY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 84..... GERMANY: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2              FRANCE
9.3.2.1            INCREASING PREVALENCE OF HIV TO SUPPORT THE MARKET GROWTH
・       TABLE 85... FRANCE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 86... FRANCE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 87........ FRANCE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 88...... FRANCE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 89.. FRANCE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 90... FRANCE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 91....... FRANCE: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3              UK
9.3.3.1            GOVERNMENT SUPPORT TO PREVENT TRANSMISSION OF HIV AND OTHER INFECTIONS WILL DRIVE MARKET GROWTH
・       TABLE 92. UK: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 93 UK: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 94 UK: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 95 UK: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 96..... UK: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 97......... UK: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 98..... UK: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4              ITALY
9.3.4.1            ITALY IS WITNESSING AN INCREASE IN THE NUMBER OF BLOOD DONORS
・       TABLE 99....... ITALY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 100..... ITALY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 101.......... ITALY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 102........ ITALY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 103 ITALY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 104.... ITALY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 105 ITALY: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5              SPAIN
9.3.5.1            INCREASING ADOPTION OF NAT TECHNOLOGY WILL SUPPORT MARKET GROWTH
・       TABLE 106.... SPAIN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 107.... SPAIN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 108......... SPAIN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 109....... SPAIN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 110 SPAIN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 111... SPAIN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 112........ SPAIN: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6              REST OF EUROPE
・       TABLE 113 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
・       TABLE 114...... ROE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 115...... ROE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 116............ ROE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 117......... ROE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 118.. ROE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 119...... ROE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 120. ROE: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4             ASIA PACIFIC
・       FIGURE 29... ASIA PACIFIC: BLOOD SCREENING MARKET SNAPSHOT
・       TABLE 121 ASIA PACIFIC: BLOOD SCREENING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 122.............. ASIA PACIFIC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 123.. ASIA PACIFIC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 124 ASIA PACIFIC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 125 ASIA PACIFIC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 126...... ASIA PACIFIC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 127.......... ASIA PACIFIC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 128 ASIA PACIFIC: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1              CHINA
9.4.1.1            CHINA HAS A HIGH PREVALENCE OF INFECTIOUS DISEASES
・       TABLE 129................................ CHINA: KEY MACROINDICATORS
・       TABLE 130.... CHINA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 131.... CHINA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 132......... CHINA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 133...... CHINA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 134... CHINA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 135... CHINA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 136........ CHINA: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2              JAPAN
9.4.2.1            RISING GERIATRIC POPULATION AND PREVALENCE OF CANCER SUPPORT MARKET GROWTH
・       TABLE 137................................ JAPAN: KEY MACROINDICATORS
・       TABLE 138.... JAPAN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 139.... JAPAN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 140......... JAPAN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 141...... JAPAN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 142... JAPAN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 143... JAPAN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 144........ JAPAN: BLOOD SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)
9.4.3              INDIA
9.4.3.1            INCREASING NUMBER OF ROAD ACCIDENTS AND RISE IN PREVALENCE OF THALASSEMIA WILL SUPPORT THE MARKET GROWTH
・       TABLE 145................................. INDIA: KEY MACROINDICATORS
・       TABLE 146.... INDIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 147.... INDIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 148.......... INDIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2019–2026 (USD MILLION)
・       TABLE 149....... INDIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)
・       TABLE 150 INDIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2019–2026 (USD MILLION)
・       TABLE 151.... INDIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 152 INDIA: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4              AUSTRALIA
9.4.4.1            INCREASED DEMAND FOR BLOOD DONATIONS WILL PROPEL MARKET GROWTH
・       TABLE 153................ AUSTRALIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 154..... AUSTRALIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 155... AUSTRALIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 156 AUSTRALIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 157......... AUSTRALIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 158. AUSTRALIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 159.. AUSTRALIA: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.5              REST OF ASIA PACIFIC
・       TABLE 160. ROAPAC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 161. ROAPAC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 162...... ROAPAC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 163.... ROAPAC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 164 ROAPAC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 165 ROAPAC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 166..... ROAPAC: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5             LATIN AMERICA
・       TABLE 167........... LATIN AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 168........... LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 169 LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 170. LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 171........... LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 172... LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 173....... LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 174..... LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.1              BRAZIL
9.5.1.1            INCREASED PREVALENCE OF CANCER WILL SUPPORT THE MARKET GROWTH
・       TABLE 175... INCIDENCE OF VARIOUS CANCERS IN BRAZIL, 2020 VS. 2025
・       TABLE 176... BRAZIL: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 177... BRAZIL: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 178........ BRAZIL: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 179..... BRAZIL: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 180.. BRAZIL: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 181.. BRAZIL: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 182....... BRAZIL: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.2              REST OF LATIN AMERICA
・       TABLE 183 ROLATAM: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 184 ROLATAM: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 185.... ROLATAM: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 186.. ROLATAM: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 187........... ROLATAM: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 188... ROLATAM: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 189.... ROLATAM: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6             MIDDLE EAST & AFRICA
9.6.1              RISING PREVALENCE OF INFECTIOUS DISEASES AND STRENGTHENING OF HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
・       TABLE 190 MIDDLE EAST & AFRICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・       TABLE 191 MIDDLE EAST & AFRICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 192 MIDDLE EAST & AFRICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2019–2026 (USD MILLION)
・       TABLE 193 MIDDLE EAST & AFRICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
・       TABLE 194 MIDDLE EAST & AFRICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 195................ MIDDLE EAST & AFRICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2019–2026 (USD MILLION)
・       TABLE 196 MIDDLE EAST & AFRICA: BLOOD SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)

10.. COMPETITIVE LANDSCAPE

10.1          OVERVIEW
10.2          KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1            OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE BLOOD SCREENING MARKET
・       TABLE 197...... OVERVIEW OF STRATEGIES DEPLOYED BY KEY BLOOD SCREENING MANUFACTURING COMPANIES
10.3          REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
・       FIGURE 30.. REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE BLOOD SCREENING MARKET
10.4          MARKET SHARE ANALYSIS
・       FIGURE 31....... BLOOD SCREENING MARKET SHARE, BY KEY PLAYER (2020)
・       TABLE 198.. BLOOD SCREENING MARKET: DEGREE OF COMPETITION
10.5          COMPANY EVALUATION QUADRANT
10.5.1            LIST OF EVALUATED VENDORS
10.5.2            STARS
10.5.3            EMERGING LEADERS
10.5.4            PERVASIVE PLAYERS
10.5.5            PARTICIPANTS
・       FIGURE 32. BLOOD SCREENING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020

10.6          COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)
10.6.1            PROGRESSIVE COMPANIES
10.6.2            STARTING BLOCKS
10.6.3            RESPONSIVE COMPANIES
10.6.4            DYNAMIC COMPANIES
・       FIGURE 33. BLOOD SCREENING MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020
10.7          COMPETITIVE BENCHMARKING
10.7.1            PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
・       FIGURE 34.... PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE BLOOD SCREENING MARKET
・       TABLE 199......................... PRODUCT FOOTPRINT OF COMPANIES
・       TABLE 200........................ REGIONAL FOOTPRINT OF COMPANIES
10.8          COMPETITIVE SCENARIO.. 176
10.8.1            PRODUCT LAUNCHES & REGULATORY APPROVALS
・       TABLE 201......................................... KEY PRODUCT LAUNCHES
10.8.2            DEALS
・       TABLE 202............................................................ KEY DEALS

11.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS, KEY INSIGHTS, RECENT DEVELOPMENTS, MNM VIEW)*
11.1          KEY PLAYERS
11.1.1            F. HOFFMANN-LA ROCHE
・       TABLE 203............ F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
・       FIGURE 35.. F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2020)
11.1.2            GRIFOLS
・       TABLE 204................................. GRIFOLS: BUSINESS OVERVIEW
・       FIGURE 36....................... GRIFOLS: COMPANY SNAPSHOT (2020)
11.1.3            ABBOTT LABORATORIES
・       TABLE 205.............. ABBOTT LABORATORIES: BUSINESS OVERVIEW
・       FIGURE 37.... ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
11.1.4            BIOMÉRIEUX
・       TABLE 206............................ BIOMÉRIEUX: BUSINESS OVERVIEW
・       FIGURE 38.................. BIOMÉRIEUX: COMPANY SNAPSHOT (2020)
11.1.5            BIO-RAD LABORATORIES
・       TABLE 207............. BIO-RAD LABORATORIES: BUSINESS OVERVIEW
・       FIGURE 39.. BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2020)
11.1.6            BECTON, DICKINSON AND COMPANY
・       TABLE 208............ BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
・       FIGURE 40.............................. BD: COMPANY SNAPSHOT (2020)

11.1.7            DANAHER CORPORATION
・       TABLE 209........... DANAHER CORPORATION.: BUSINESS OVERVIEW
・       FIGURE 41.. DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.8            DIASORIN
・       TABLE 210................................ DIASORIN: BUSINESS OVERVIEW
・       FIGURE 42..................... DIASORIN: COMPANY SNAPSHOT (2020)
11.1.9            SIEMENS HEALTHINEERS
・       TABLE 211............ SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
・       FIGURE 43.. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020)
11.1.10         THERMO FISHER SCIENTIFIC, INC.
・       TABLE 212........ THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
・       FIGURE 44........ THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
(BUSINESS OVERVIEW, PRODUCTS, KEY INSIGHTS, RECENT DEVELOPMENTS, MNM VIEW)*
11.2          OTHER PLAYERS
11.2.1            ORTHO CLINICAL DIAGNOSTICS, INC.
11.2.2            GE HEALTHCARE
11.2.3            MERCK KGAA
11.2.4            PERKINELMER
11.2.5            BIO-TECHNE CORPORATION
11.2.6            GFE
11.2.7            TRINITY BIOTECH.. 221
11.2.8            J. MITRA & CO. PVT. LTD.
11.2.9            MINDRAY
11.2.10         MACCURA BIOTECHNOLOGY CO., LTD.
11.2.11         IMMUCOR, INC.
11.2.12         CELLABS
11.2.13         ABNOVA CORPORATION
11.2.14         ENZO BIOCHEM, INC.
11.2.15         CEPHEID
12.. APPENDIX


△ 一番上に戻る